Licostinel
Licostinel (also known as ACEA-1021) is a drug that acts as a competitive antagonist at the glycine site of the NMDA receptor. It was initially developed for the treatment of stroke and traumatic brain injury.
Mechanism of Action[edit]
Licostinel works by inhibiting the activity of the NMDA receptor, which is a type of glutamate receptor. The NMDA receptor plays a crucial role in synaptic plasticity, memory, and learning. By blocking the glycine site on the NMDA receptor, Licostinel reduces the excitotoxicity that occurs during ischemic stroke and traumatic brain injury.
Clinical Trials[edit]
Licostinel has undergone several clinical trials to evaluate its efficacy and safety. Early studies showed promise in reducing the extent of brain damage following a stroke. However, subsequent trials did not demonstrate significant clinical benefits, leading to a halt in its development for this indication.
Potential Applications[edit]
Despite the setbacks in clinical trials for stroke, Licostinel has been studied for other potential applications, including the treatment of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Research is ongoing to determine its efficacy in these areas.
Side Effects[edit]
The side effects of Licostinel are similar to those of other NMDA receptor antagonists. Common side effects include dizziness, nausea, and headache. More severe side effects can include hallucinations and psychosis.
See Also[edit]
References[edit]
External Links[edit]
-
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
